Patents matching “inhibitor”

US 6194460

Composition for treating cough induced by angiotensin converting enzyme inhibitors

Montefiore Medical Center · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6194390

Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6194206

Use of oligonucleotide telomerase inhibitors to reduce telomere length

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6187296

Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease

The Board of Regents of the University of Oklahoma · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6184363

Inhibitors of .beta.-lactamases and uses therefor

Northwestern University · Granted Feb 6, 2001 · Expires Feb 1, 2021

US 6174666

Method of eliminating inhibitory/instability regions from mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 16, 2001 · Expires Jan 11, 2021

US 6169074

Peptide inhibitors of neurotransmitter secretion by neuronal cells

The Regents of the University of California · Granted Jan 2, 2001 · Expires Dec 28, 2020

US 6162432

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 19, 2000 · Expires Dec 14, 2020

US 6162828

Cysteine protease inhibitor

Takeda Chemical Industries Ltd. · Granted Dec 19, 2000 · Expires Dec 14, 2020

US 6162800

N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

US 6162790

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

US 6156723

Compositions comprising inhibitors of estrogen response

The Regents of the University of California · Granted Dec 5, 2000 · Expires Nov 30, 2020

US 6150416

Nanomolar, non-peptide inhibitors of cathepsin D

The Regents of the University of California · Granted Nov 21, 2000 · Expires Nov 16, 2020

US 6147080

Inhibitors of p38

Vertex Pharmaceuticals Incorporated · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6143719

Bradykinin analogs as selective thrombin inhibitors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 7, 2000 · Expires Nov 2, 2020

US 6136787

Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

Vertex Pharmaceuticals Incorporated · Granted Oct 24, 2000 · Expires Oct 19, 2020

US 6133256

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6127372

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2000 · Expires Sep 28, 2020

US 6121266

Pyridazines as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2000 · Expires Sep 14, 2020

US 6118001

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Sep 12, 2000 · Expires Sep 7, 2020

US 6114545

Inhibitors of cholesterol esterase

The Regents of the University of New Mexico · Granted Sep 5, 2000 · Expires Aug 31, 2020

US 6114372

Peptidyl compounds having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Sep 5, 2000 · Expires Aug 31, 2020

US 6111065

Peptide inhibitors of inflammation mediated by selectins

The Board of Regents of the University of Oklahoma · Granted Aug 29, 2000 · Expires Aug 24, 2020

US 6110889

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System · Granted Aug 29, 2000 · Expires Aug 24, 2020